Ross Muken
Stock Analyst at Evercore ISI Group
(1.66)
# 2,979
Out of 4,814 analysts
44
Total ratings
57.14%
Success rate
-0.04%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ross Muken
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Maintains: In-Line | $190 → $225 | $105.93 | +112.40% | 6 | Nov 7, 2024 | |
| PDCO Patterson Companies | Maintains: In-Line | $23 → $22 | $31.33 | -29.78% | 4 | Oct 8, 2024 | |
| ICLR ICON Public Limited Company | Maintains: Outperform | $360 → $350 | $139.30 | +151.26% | 7 | Oct 8, 2024 | |
| HSIC Henry Schein | Maintains: In-Line | $70 → $74 | $64.28 | +15.12% | 8 | Oct 8, 2024 | |
| A Agilent Technologies | Maintains: In-Line | $126 → $130 | $102.47 | +26.87% | 11 | Jul 2, 2024 | |
| QGEN Qiagen | Downgrades: In-Line | n/a | $40.72 | - | 2 | Jul 16, 2019 | |
| CAH Cardinal Health | Initiates: In-Line | $67 | $134.68 | -50.25% | 2 | Jan 5, 2018 | |
| ILMN Illumina | Initiates: Outperform | $250 | $71.16 | +251.32% | 2 | Jan 4, 2018 | |
| TMO Thermo Fisher Scientific | Initiates: Outperform | $220 | $436.79 | -49.63% | 1 | Jan 4, 2018 | |
| MBLY Mobileye Global | Downgrades: In-Line | n/a | $11.92 | - | 1 | Mar 13, 2017 |
Charles River Laboratories International
Nov 7, 2024
Maintains: In-Line
Price Target: $190 → $225
Current: $105.93
Upside: +112.40%
Patterson Companies
Oct 8, 2024
Maintains: In-Line
Price Target: $23 → $22
Current: $31.33
Upside: -29.78%
ICON Public Limited Company
Oct 8, 2024
Maintains: Outperform
Price Target: $360 → $350
Current: $139.30
Upside: +151.26%
Henry Schein
Oct 8, 2024
Maintains: In-Line
Price Target: $70 → $74
Current: $64.28
Upside: +15.12%
Agilent Technologies
Jul 2, 2024
Maintains: In-Line
Price Target: $126 → $130
Current: $102.47
Upside: +26.87%
Qiagen
Jul 16, 2019
Downgrades: In-Line
Price Target: n/a
Current: $40.72
Upside: -
Cardinal Health
Jan 5, 2018
Initiates: In-Line
Price Target: $67
Current: $134.68
Upside: -50.25%
Illumina
Jan 4, 2018
Initiates: Outperform
Price Target: $250
Current: $71.16
Upside: +251.32%
Thermo Fisher Scientific
Jan 4, 2018
Initiates: Outperform
Price Target: $220
Current: $436.79
Upside: -49.63%
Mobileye Global
Mar 13, 2017
Downgrades: In-Line
Price Target: n/a
Current: $11.92
Upside: -